• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH

ALTERITY THERAPEUTICS LIMITED - Discussion

16.7% ! 1.0¢
Market Cap $108.7M  !
Healthcare Biotechnology
Add to My Watchlist

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Alterity Therapeutics Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread IronPig 2.6K 860K 3 31/01/25
31/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread groins 2.6K 860K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread groins 2.6K 860K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread Scottsmyname 2.6K 860K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread RockstarJones 2.6K 860K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread Scottsmyname 2.6K 860K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread groins 2.6K 860K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread Scottsmyname 2.6K 860K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread GazBusey 507 168K 29 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 29
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 7 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 7
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread rakeshnirzari1 507 168K 4 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread rakeshnirzari1 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Alterity MST Financial Updated Report Thread rakeshnirzari1 3 1.3K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RebekahChambers 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread ASX-DayTrader 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Alterity MST Financial Updated Report Thread tin_shed_trader 3 1.3K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RockstarJones 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
Metals & Mining SECTOR NEWS

Could this be the next U.S. Antimony Play?

RMX
16 Sep 2025
RED MOUNTAIN MINING LIMITED
Discover Utah Antimony right-arrow Created with Sketch.
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Stockman 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RockstarJones 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Alterity MST Financial Updated Report Thread groins 3 1.3K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RockstarJones 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 168K 8 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Stockman 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Stockman 507 168K 11 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 11
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread lloydray 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 5 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 168K 16 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 16
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread groins 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Alterity MST Financial Updated Report Thread Kyriaco 3 1.3K 11 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 3 Views Created with Sketch. 1.3K Likes Created with Sketch. 11
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread lloydray 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Stockman 507 168K 8 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread IAmShovel 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread lloydray 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RebekahChambers 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread HoldingPattern 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread HoldingPattern 507 168K 13 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 13
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread lloydray 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread supernologic 507 168K 12 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 12
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RebekahChambers 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread lloydray 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RebekahChambers 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread RebekahChambers 507 168K 10 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 10
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread ZF777 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread tin_shed_trader 507 168K 5 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 168K 6 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread MrJesse 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread johnrap 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread aribeth 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Klotho 507 168K 4 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread ASX-DayTrader 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread omygollygosh 507 168K 4 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread aribeth 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread tin_shed_trader 507 168K 12 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 12
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread tin_shed_trader 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Jasper22 507 168K 6 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Jasper22 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread ASX-DayTrader 507 168K 6 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread CatmanRules 507 168K 4 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread rakeshnirzari1 507 168K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Mateo335 507 168K 5 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 5
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 168K 8 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 8
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread CatmanRules 507 168K 4 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread itsagas 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 4 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread GazBusey 507 168K 6 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Jasper22 507 168K 10 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 10
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread micknleigh 507 168K 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 1
ASX - By Stock ATH Ann: Application for quotation of securities - ATH Thread ASX News 0 619 1 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 619 Likes Created with Sketch. 1
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread amb005 507 168K 7 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 7
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread CatmanRules 507 168K 6 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 6
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Bathurst 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread groins 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread groins 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread lwlinwei 507 168K 0 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 0
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread groins 2.6K 860K 3 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 3
ASX - By Stock ATH Re: Stock price - ATH/ATHE Thread nottawombat 2.6K 860K 4 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 2.6K Views Created with Sketch. 860K Likes Created with Sketch. 4
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Scottsmyname 507 168K 2 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 2
ASX - By Stock ATH Re: Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy Thread Kyriaco 507 168K 18 30/01/25
30/01/25 ASX - By Stock Thread Comments Created with Sketch. 507 Views Created with Sketch. 168K Likes Created with Sketch. 18
refresh Created with Sketch. REFRESH

Featured News

RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.0¢ 		Change
-0.002(16.7%) 		Mkt cap ! $108.7M
Open High Low Value Volume
1.2¢ 1.2¢ 1.0¢ $286.3K 26.15M

Buyers (Bids)

No. Vol. Price($)
54 24350218 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 18128393 5
View Market Depth
Last trade - 16.12pm 16/09/2025 (20 minute delay) ?
ATH (ASX) Chart

Top Stories

Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner

In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
Market Close: Asian markets are visibly cautious, and gold profit-taking underscores that Good Afternoon and Welcome to HotCopper’s Market Close for Tuesday 16 September, I’m Jon Davidson. The index came back to life on Tuesday after Wall Street notched fresh records overnight, US futures just in the green once more in the final hour of trade. The next ...
Amaero's big move: Exclusive deal, big targets, and a lot on the line Amaero has just pulled off a deal that establishes its first-mover advantage: An exclusive five-year supply agreement with Titomic.
Tuesday's HotCopper trends: Race Oncology, Paladin Energy, and other daily winners | Sep 16 Race Oncology has been trending on the HotCopper forums after the biotech firm submitted an intellectual property patent application.
Future Battery Minerals identifies strong regolith gold anomalism at Canyon Future Battery MD and CEO, Nick Rathjen, joins HotCopper to unpack the company's glittering assay results at its Miriam project.

Featured News

NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.